A web of mail-order pharmacies, wholesalers and patient services groups connected to the self-styled largest Pentecostal ...

Healthcare agencies remain at the forefront of pharmaceutical marketing, but new technologies and shifting political dynamics ...

After the drug’s local license holder called for a brief pause in new patient starts last week, doctors in Japan can once ...

Gilead Sciences and the World Health Organization (WHO) are doubling down on a pact to eliminate deadly parasitic disea | ...

An Ipsen-commissioned survey has identified widespread problems with the transition from pediatric to adult healthcare, ...

After some six years at the post, Amgen’s finance chief is telegraphing his exit from the California pharma by early next ...

Tarsus Pharmaceuticals has spent the past three years marketing its way out of a largely unknown but stigmatized condition: ...

Bristol Myers Squibb is the latest large pharma company to be making a major bet on artificial intelligence, announcing a sweeping agreement with Anthropic to deploy its AI tool Claude as the “shared ...

BeOne Medicines has tapped former professional soccer goalkeeper Tim Howard as the face of its first major corporate campaign ...

Gilead Sciences has broadened its partnership with Korean manufacturer Yuhan, agreeing to a 210 billion Korean won ($140 million) supply deal for active pharmaceutical ingredients (API) for an ...

Roche has signed a voluntary license agreement providing its popular influenza antiviral drug Xofluza (baloxavir marboxil) ...

President Donald Trump earlier this year bought as much as $680,000 in stock of Eli Lilly, the maker of blockbuster obesity ...